This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This DLEC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 879-908 amino acids from the Central region of human DLEC1.
DLEC1
Reaktivität: Human
ELISA, WB
Wirt: Kaninchen
Polyclonal
APC
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
DLEC1
(Deleted in Lung and Esophageal Cancer 1 (DLEC1))
DLC1 antikoerper, F56 antikoerper, D630005C06Rik antikoerper, deleted in lung and esophageal cancer 1 antikoerper, deleted in lung and esophageal cancer protein 1 antikoerper, DLEC1 antikoerper, LOC100187070 antikoerper, Dlec1 antikoerper
Hintergrund
This gene contains 37 exons, spans approximately 59-kb, and is located in the 3p22-p21.3 chromosomal segment that is commonly deleted in various carcinomas. Several alternatively spliced transcripts have been observed that contain disrupted coding regions and likely encode nonfunctional proteins. Aberrant transcription of this gene may be involved in carcinogenesis of the lung, esophagus, and kidney.